Found 35 matching trials
P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome PHASE2 The primary purpose of the study is to investigate the effects of high-dose...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs) PHASE2 This is a Phase II, open-label multicentre, randomised study to assess the ...
Show More Location
Hospices Civils de Lyon
Learn More & Join Trial
Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors PHASE2 The aim of this study is to evaluate the diagnostic performance of Al18F-NO...
Show More Location
Universitaire Ziekenhuizen Leuven
Learn More & Join Trial
Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) N/A An observational time and motion study in a clinical oncology setting is ut...
Show More Location
The University of Arizona Cancer Center
Learn More & Join Trial
Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR PHASE4 The purpose of this study is to assess the efficacy, safety and patient acc...
Show More Location
Westmead Hospital
Learn More & Join Trial
A Phase 1 Study to Evaluate the Relative Bioavailability of Octreotide Acetate Tablets(T25) Compared to MYCAPSSA® and The Food Effect on Pharmacokinetics Of Octreotide Acetate Tablets(T25) PHASE1 The goal of this clinical trial\] is to to Assess the Food Effect on the Re...
Show More Location
Zibo Central Hospital
Learn More & Join Trial
Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors PHASE2 RATIONALE: Specialized radiation therapy that delivers a high dose of radia...
Show More Location
Vanderbilt-Ingram Cancer Center
Learn More & Join Trial
Sandostatin LAR® Depot in Patients With Primary Insulin Hypersecretion (PIH) and at Least Moderate Obesity PHASE2 This study is in patients with at least moderate obesity (Body Mass Index \...
Show More Location
New Orleans Center for Clinical Research
Learn More & Join Trial
Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor PHASE3 The purpose of this study was to evaluate whether everolimus 10 mg / day ad...
Show More Location
University of Arizona / Arizona Cancer Center Deptof Uof A/Arizona Cancer(2)
Learn More & Join Trial
Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients PHASE3 The purpose of the study is to evaluate efficacy and safety of Peptide Rece...
Show More Status
Active Not Recruiting
Location
Banner Health d.b.a. Banner MD Anderson Cancer Center
Learn More & Join Trial